|
Compass Therapeutics ، Inc. (CMPX) DCF تقييم
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Compass Therapeutics, Inc. (CMPX) Bundle
تبسيط تقييم Compass Therapeutics ، Inc. (CMPX) مع هذه الآلة الحاسبة DCF القابلة للتخصيص! يضم REAL Compass Therapeutics ، Inc. (CMPX) ومدخلات التنبؤ القابلة للتعديل ، يمكنك اختبار السيناريوهات وكشف القيمة العادلة Compass Therapeutics ، Inc. (CMPX) في دقائق.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Revenue Growth, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITDA | -31.2 | -25.3 | -29.6 | -37.4 | -48.5 | .0 | .0 | .0 | .0 | .0 |
| EBITDA, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Depreciation | 2.1 | 2.4 | 1.6 | 1.9 | 1.9 | .0 | .0 | .0 | .0 | .0 |
| Depreciation, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| EBIT | -33.3 | -27.7 | -31.2 | -39.3 | -50.4 | .0 | .0 | .0 | .0 | .0 |
| EBIT, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Total Cash | 25.3 | 47.1 | 144.5 | 186.6 | 152.5 | .0 | .0 | .0 | .0 | .0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Inventories | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Accounts Payable | .6 | 1.1 | .9 | 3.4 | 4.1 | .0 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Capital Expenditure | -.5 | -.1 | -1.6 | -.2 | .0 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | 100 | 100 | 100 | 100 | 100 | 0 | 0 | 0 | 0 | 0 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -33.4 | -27.8 | -31.4 | -36.9 | -50.4 | .0 | .0 | .0 | .0 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -31.1 | -25.0 | -31.5 | -32.7 | -47.8 | -4.1 | .0 | .0 | .0 | .0 |
| WACC, % | 8.62 | 8.62 | 8.62 | 8.61 | 8.62 | 8.61 | 8.61 | 8.61 | 8.61 | 8.61 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -3.8 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | -4 | |||||||||
| Net Debt | -22 | |||||||||
| Equity Value | 19 | |||||||||
| Diluted Shares Outstanding, MM | 127 | |||||||||
| Equity Value Per Share | 0.15 |
What You Will Get
- Comprehensive CMPX Financials: Access both historical and projected data for precise valuation.
- Customizable Inputs: Adjust discount rates, tax implications, revenue growth, and capital investment figures.
- Real-Time Calculations: Dynamic computation of intrinsic value and NPV.
- Scenario Analysis: Explore various scenarios to assess Compass Therapeutics’ future prospects.
- User-Friendly Interface: Designed for professionals while remaining approachable for newcomers.
Key Features
- Comprehensive Data Access: Compass Therapeutics’ historical financial statements and detailed projections.
- Customizable Variables: Adjust WACC, tax rates, revenue growth, and EBITDA margins to fit your analysis.
- Real-Time Insights: Instantly view Compass Therapeutics’ intrinsic value as it updates live.
- Intuitive Visualizations: Dashboard graphs present valuation results and essential metrics clearly.
- Designed for Precision: A robust tool tailored for analysts, investors, and finance professionals.
How It Works
- Step 1: Download the Excel file for Compass Therapeutics, Inc. (CMPX).
- Step 2: Review Compass Therapeutics' pre-filled financial data and forecasts.
- Step 3: Modify key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Observe the DCF model update in real-time as you adjust your assumptions.
- Step 5: Analyze the outputs and leverage the results for informed investment decisions.
Why Choose This Calculator?
- Designed for Healthcare Professionals: A sophisticated tool utilized by analysts, CFOs, and biotech consultants.
- Comprehensive Data: Compass Therapeutics’ historical and projected financials preloaded for precise analysis.
- Scenario Analysis: Effortlessly simulate various forecasts and assumptions.
- Clear Outputs: Automatically computes intrinsic value, NPV, and essential metrics.
- User-Friendly: Step-by-step guidance walks you through the entire process.
Who Should Use This Product?
- Healthcare Professionals: Understand innovative therapies and their implications in clinical settings.
- Researchers: Integrate cutting-edge treatment models into studies or publications.
- Investors: Evaluate your investment strategies and assess the potential of Compass Therapeutics, Inc. (CMPX).
- Pharmaceutical Analysts: Enhance your analysis with a comprehensive framework for evaluating biotech companies.
- Biotech Entrepreneurs: Learn from the strategies used by established firms like Compass Therapeutics, Inc. (CMPX).
What the Template Contains
- Pre-Filled Data: Includes Compass Therapeutics' historical financials and projections.
- Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
- Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
- Key Financial Ratios: Analyze Compass Therapeutics' profitability, efficiency, and leverage.
- Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
- Clear Dashboard: Charts and tables summarizing key valuation results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.